Article Versions Notes

Suzuki H, Ohishi T, Nakamura T, Yanaka M, Handa S, Tanaka T, Kaneko MK, Kato Y. A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. Antibodies. 2025; 14(3):67. https://doi.org/10.3390/antib14030067

Suzuki, Hiroyuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Saori Handa, Tomohiro Tanaka, Mika K. Kaneko, and Yukinari Kato. 2025. "A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models" Antibodies 14, no. 3: 67. https://doi.org/10.3390/antib14030067

Suzuki, H., Ohishi, T., Nakamura, T., Yanaka, M., Handa, S., Tanaka, T., Kaneko, M. K., & Kato, Y. (2025). A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. Antibodies, 14(3), 67. https://doi.org/10.3390/antib14030067